Actively Recruiting
The SWITCH Dietary and Behavioural Intervention Study
Led by Chalmers University of Technology · Updated on 2025-05-15
300
Participants Needed
1
Research Sites
91 weeks
Total Duration
On this page
Sponsors
C
Chalmers University of Technology
Lead Sponsor
G
Göteborg University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The overall objective of this study is to evaluate the effectiveness of an optimized lifestyle intervention based on dietary advice, behavioral support, and provision of key foods compared to dietary advice with behavioral support or dietary advice alone. The intervention aims to improve nutritional status, metabolic risk factors, and planetary sustainability. A total of 300 participants (150 men and 150 women) who meet all inclusion criteria and none of the exclusion criteria will be recruited. The study will be conducted at the Centre for Lifestyle Intervention at Östra Hospital in Gothenburg, led by researchers from Chalmers University of Technology, University of Gothenburg, and Sahlgrenska University Hospital. Participants will be recruited from two different socioeconomic areas in Gothenburg to examine how dietary interventions function in diverse population groups. The study follows a twelve-week randomized, controlled, parallel intervention design. Participants will be randomized into three groups, each with 100 individuals: Optimized lifestyle intervention group - receiving dietary advice, behavioral support, and provision of key foods. Behavioral support intervention group - receiving dietary advice and behavioral support. Control group - receiving dietary advice according to the SWITCH diet. The SWITCH diet, developed within the EU project SWITCH, is designed to align with European dietary guidelines and promote sustainable and healthy eating habits. It emphasizes whole grains, vegetables, fruits, legumes, and sustainable seafood while limiting processed foods, added sugars, and salt. Throughout the study, participants will undergo clinical assessments at baseline, midpoint (week 7), and endpoint (week 13). Key measurements include anthropometric data, blood pressure, blood glucose, blood lipids, and inflammatory markers. Dietary intake and sustainability aspects of food consumption will also be evaluated. Participants in the intervention groups will receive personalized coaching and access to practical resources, such as meal plans, recipes, and visual educational materials. The primary outcome of the study is the difference in cardiometabolic risk factors (e.g., blood lipids, blood pressure, glucose, insulin resistance markers) between the intervention groups. Secondary outcomes include changes in dietary intake, nutritional status markers, inflammatory markers, and sustainability measures (e.g., CO₂ emissions, land use, biodiversity impact). Additionally, exploratory analyses will investigate associations between diet, lifestyle changes, gut microbiota, and metabolic responses. This study aims to generate valuable insights into the effectiveness of different dietary intervention strategies in real-life Nordic conditions. The results will contribute to the development of evidence-based recommendations for sustainable and health-promoting dietary patterns.
CONDITIONS
Official Title
The SWITCH Dietary and Behavioural Intervention Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18-70 years
- Body mass index 25-35 kg/m2
- Stable dietary patterns with no specific dieting in the last 4 weeks
- Willingness to follow the advised diet and consume provided key foods
- Stable medications for at least 14 days before study start
- Access to a freezer at -186 C to store key foods at home
- Signed informed consent
You will not qualify if you...
- Current infection or relevant illness
- Cardiovascular events (heart attack or stroke) in the previous 6 months unless disease is stable
- Diagnosis of diabetes of any type
- Blood pressure 65185/105 mmHg
- Serum cholesterol 658 mmol/L
- Fasting blood glucose above 7 mmol/L
- Current use of GLP-1 receptor agonists
- History of stomach or gastrointestinal diseases such as inflammatory bowel disease, Crohn's disease, hepatitis, malabsorption, or celiac disease
- Severe and recent irritable bowel syndrome within the last 6 months
- Previous major gastrointestinal surgeries including colostomy, bowel resection, or bariatric surgery
- Renal or liver failure based on creatinine and liver enzyme levels
- Anemia or hemoglobin below 100 g/L
- Blood donation or participation in blood sampling studies within 30 days
- Currently on a specific or incompatible diet such as strict vegan or vegetarian
- Food allergies or intolerances to foods included in the intervention
- High level of regular physical activity at baseline
- History of drug or alcohol abuse
- Inability to understand written or spoken Swedish
- Any other reason judged by investigators for lack of suitability
- Pregnancy, lactation, or planning pregnancy during the study
- Participation in another interfering research study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Center for Lifestyle Interventions, Sahlgrenska University Hospital, Östra
Gothenburg, Sweden
Actively Recruiting
Research Team
R
Rikard Landberg, Professor
CONTACT
M
Malin Barman, Docent
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here